ECAT vs EBS: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

EBS has stronger fundamentals based on our AI analysis.

ECAT
BlackRock ESG Capital Allocation Term Trust
HOLD
15%
Confidence
VS
EBS
Emergent BioSolutions Inc.
BUY
72%
Confidence

ECAT vs EBS Fundamental Comparison

Metric ECAT EBS
Revenue N/A $742.9M
Net Income N/A $52.6M
Net Margin N/A 7.1%
ROE N/A 10.1%
ROA N/A 4.0%
Current Ratio N/A 5.01x
Debt/Equity N/A 1.13x
EPS N/A $0.93

Green = Better metric | Red = Weaker metric

View Full ECAT Analysis →
View Full EBS Analysis →

You Might Also Compare

ECAT vs AAPL EBS vs MSFT ECAT vs GOOGL EBS vs AMZN

ECAT vs EBS: Frequently Asked Questions

Is ECAT or EBS a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), EBS has stronger fundamentals. ECAT is rated HOLD (15% confidence) while EBS is rated BUY (72% confidence). This is not investment advice.

How does ECAT compare to EBS fundamentally?

BlackRock ESG Capital Allocation Term Trust has ROE of N/A vs Emergent BioSolutions Inc.'s 10.1%. Net margins are N/A vs 7.1% respectively.

Which stock pays higher dividends, ECAT or EBS?

ECAT has a dividend yield of N/A or no dividend while EBS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ECAT or EBS for long term?

For long-term investing, consider that ECAT has HOLD rating with 15% confidence, while EBS has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ECAT vs EBS?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ECAT vs EBS, the AI consensus favors EBS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.